PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1064092
PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1064092
According to SPER Market Research, the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS worldwide, increase funding in biomedical sector, and shift towards personalized medicine, technological advancements; are the growths driving factors.
Because of the increased awareness about the infection, research work also increased. Due to COVID-19 epidemic, testing, diagnosing of the infection increased by the companies. That leads to huge opportunities for companies to make profits.
Rising incidences of HIV/AIDS globally gave impetus for the advancement and up gradation of technologies, there increased demand for personalized medicine in turn funding of government in Biomedical Research, these are the key elements for the growth of this market.
Alternative technologies (ELISA, LC/MS, and LFIA) are user friendly, high accuracy, Precision, high speed, consistency, sensitivity, and can handle multiple samples as compared to existing technologies (Western Blotting).
To get a reliable, quantitative result there is need of high efficiency, precise methodology, analytical knowledge, widespread labour-intensive managing, handiness, and firm observance of protocols. The data variations & Failure rates are high in Western Blotting.
There will be huge opportunities in the Asia Pacific, Latin America, the Middle East & Africa, due to increasing the innovation in the research & development, health care market, personalized medicine, developments in research infrastructure and the economical manufacturing cost of emerging APAC countries encourage market players to invest.
Based upon the product, the Global western blotting market is segmented as; Consumables (Reagents & Buffers, Antibodies & Conjugates, Kits, Membranes & Filter Papers, Other Consumables), Instruments {Electrophoresis Instruments, Blotting Systems, Imagers (Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers)}.
Based upon the Application, the Global western blotting market is segmented as; Biomedical Research, Clinical Diagnostics (Hepatitis, HIV, Lyme disease, Other Diseases), Agricultural Applications, Other Applications
Based upon the End Users, the Global western blotting market is segmented as; Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users.
North America dominates the highest share of this market, is due to the presence of big companies, increase in investment in biomedical research, and demand for personalized medicine.